Stay updated on Nivolumab Combo in Early Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo in Early Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo in Early Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0 (replacing v3.4.3).
    Difference
    0.0%
    Check dated 2026-03-18T18:02:30.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T16:38:38.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The study record now shows Terminated due to slow accrual and lack of funding, and results have been posted. The summary also includes the Major Pathologic Response (mpCR) definition and related outcome measures.
    Difference
    3%
    Check dated 2026-02-25T08:57:01.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. The prior government funding/status notice (Revision: v3.4.1) was removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:19:24.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Added a site-wide notice about potential delays due to a lapse in government funding and updated the page revision to v3.4.1; the previous revision v3.4.0 was removed.
    Difference
    0.4%
    Check dated 2026-02-04T04:09:52.000Z thumbnail image
  9. Check
    78 days ago
    Change Detected
    Summary
    The glossary is now shown by default and the QC status label has been updated to 'Last Update Submitted that Met QC Criteria' with a new version reference v3.4.0. The previous label 'Last Update Submitted that met QC Criteria', the 'No FEAR Act data' label, and the older version reference v3.3.4 were removed.
    Difference
    0.2%
    Check dated 2026-01-28T01:33:42.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo in Early Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Early Lung Cancer Clinical Trial page.